drugset / Trial / NCT03381807
Human Amniotic Epithelial Stem Cell in Treatment of Refractory Severe Intrauterine Adhesion
Phase 0
Unknown
20 enrolled
Second Affiliated Hospital, School of Medicine, Zhejiang University
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China · collab
NaSingle-groupOpen-labelTreatment
Summary
This project will investigate the safety and effectiveness of human amniotic epithelial stem cells for treatment of severe refractory Asherman's syndrome.
Timeline
- Start
- 2020-09-16
- Primary completion
- 2022-09-01
- Completion
- 2023-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hAESCs | Cell therapy | 5e+07 cells | Other |